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l-pipecolic acid is a nonproteinogenic amino acid of lysine me-
tabolism. In humans, pipecolate is derived from the saccharopine 
branch of lysine catabolism and by an alternative lysine deg-
radation pathway initiated by α–deamination of lysine [Struys 
and Jakobs, 2010]. l-pipecolate is oxidized to Δ1-piperideine-
6-carboxylate (P6C) by the flavoenzyme pipecolate oxidase 
(PIPOX) (Fig. 1A). Spontaneous hydrolysis of P6C then gener-
ates α-aminoadipate semialdehyde (AAS), an intermediate that is 
also generated from saccharopine by AAS synthase of the main 
lysine degradation pathway [Struys and Jakobs, 2010]. AAS is 
subsequently oxidized by NAD+-dependent AAS dehydrogenase 
(AASDH1, also known as aldehyde dehydrogenase 7A1) [Luo and 
Tanner, 2015] to form α-aminoadipic acid (AAA), which is even-
tually converted to glutaryl-CoA via α-ketoadipic acid [Struys 
and Jakobs, 2010]. 
Human PIPOX is a polypeptide of 390 residues with a mo-
lecular weight of 44 kDa and contains a covalently bound flavin 
cofactor [Dodt et al., 2000]. Characterization of PIPOX from dif-
ferent mammalian sources shows that in addition to oxidizing 
pipecolate, PIPOX can utilize sarcosine and proline as alterna-
tive substrates, albeit with lower efficiency [Mihalik et al., 1991; 
Dodt et al., 2000]. Elevated pipecolic acid concentration in serum 
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Abstract 
Pipecolate, an intermediate of the lysine catabolic pathway, is oxidized to Δ1-piperideine-6-carboxylate (P6C) by the flavoenzyme l-
pipecolate oxidase (PIPOX). P6C spontaneously hydrolyzes to generate α-aminoadipate semialdehyde, which is then converted into 
α-aminoadipate acid by α-aminoadipatesemialdehyde dehydrogenase. l-pipecolate was previously reported to protect mamma-
lian cells against oxidative stress. Here, we examined whether PIPOX is involved in the mechanism of pipecolate stress protection. 
Knockdown of PIPOX by small interference RNA abolished pipecolate protection against hydrogen peroxide-induced cell death in 
HEK293 cells suggesting a critical role for PIPOX. Subcellular fractionation analysis showed that PIPOX is localized in the mitochon-
dria of HEK293 cells consistent with its role in lysine catabolism. Signaling pathways potentially involved in pipecolate protection 
were explored by treating cells with small molecule inhibitors. Inhibition of both mTORC1 and mTORC2 kinase complexes or inhi-
bition of Akt kinase alone blocked pipecolate protection suggesting the involvement of these signaling pathways. Phosphorylation 
of the Akt downstream target, forkhead transcription factor O3 (FoxO3), was also significantly increased in cells treated with pipe-
colate, further implicating Akt in the protective mechanism and revealing FoxO3 inhibition as a potentially key step. The results pre-
sented here demonstrate that pipecolate metabolism can influence cell signaling during oxidative stress to promote cell survival 
and suggest that the mechanism of pipecolate protection parallels that of proline, which is also metabolized in the mitochondria. 
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(hyperpipecolic acidaemia) is used as a marker of pyridoxine de-
pendent epilepsy and AASDH deficiency [Stockler et al., 2011], 
and is associated with peroxisome biogenesis disorders such as 
Zellweger syndrome [Wanders et al., 1988; Moser et al., 1989]. 
Our interest in l-pipecolic acid is from a previous study in 
which we tested the ability of proline and proline analogs to 
protect mammalian cells against oxidative stress. In addition to 
proline, we found that pipecolate, a six-member proline ana-
log, significantly increased cell survival after exposure to H2O2 
stress [Krishnan et al., 2008]. The mechanism by which pro-
line improves cell survival was shown to be mediated by pro-
line dehydrogenase (PRODH) [Natarajan et al., 2012]. PRODH 
is a mitochondrial enzyme that performs the first step of pro-
line degradation by catalyzing the oxidation of proline to Δ1-
pyrroline-5-carboxylate (P5C) (Fig. 1B), which is then converted 
into glutamate by P5C dehydrogenase. Knockdown of PRODH 
eliminated the protective effect of proline against H2O2 stress 
[Natarajan et al., 2012]. Additionally, it was shown that proline 
and PRODH increase activation of Akt signaling during stress 
suggesting a mechanism for how proline enhances cell survival 
[Natarajan et al., 2012]. 
Here we investigate the mechanism of pipecolate protec-
tion against H2O2 induced cell death. PIPOX catalyzes the oxi-
dation of l-pipecolate in a reaction analogous to PRODH (Fig. 
1A) suggesting that similar to proline, the protective effect of 
pipecolate may depend on this first oxidative step. The role 
of PIPOX in pipecolate protection was thus examined and the 
mechanistic target of rapamycin complex (mTOR) and Akt ki-
nase were explored to test their potential involvement in pipe-
colate protection. Subcellular localization of PIPOX was also as-
sessed to establish whether PIPOX is expressed in mitochondria. 
We found that in HEK293 cells a majority of PIPOX localizes to 
mitochondria and our results suggest that the mechanism by 
which pipecolate provides cellular stress protection parallels that 
of proline. 
Materials and Methods 
Materials 
Unless stated otherwise, all chemicals, enzymes, and buffers 
were purchased from Fisher Scientific and Sigma–Aldrich, Inc. 
For this study, we used human embryonic kidney 293 (HEK293) 
cells purchased from ATCC. 
Antibodies 
Antibodies recognizing VDAC/Porin (#V2139) and b-Actin 
(#A5441) were from Sigma. The monoclonal antibody against 
PIPOX (PIPOX F-9, #sc-166749) was from Santa–Cruz and an-
ticatalase antibody (#ab15834) was from Abcam. Antibodies 
against phospho-Akt T308 (#4056), phospho-Akt S473 (#4058), 
phospho- JNK (#4668), phospho-FoxO3 (Thr32) (#9464) and to-
tal forms of FoxO3 (#2497), Akt (#4685), and JNK (#9252) were 
from Cell Signaling Technology. Horseradish peroxidase-labeled 
anti-mouse (#NA931), and anti-rabbit (#RPN4301) secondary 
antibodies were from GE Healthcare. 
Stress Tests and Cell Viability 
HEK293 cells were grown in Dulbecco’s Modified Eagle’s Me-
dium (DMEM) supplemented with 10% FBS and penicillin-strep-
tomycin (100 U/ml). For stress treatments, HEK293 were grown 
to 80% confluence and then pretreated with and without l-
pipecolate in serum containing medium for 12 h. After the pre-
treatment period, cells were exposed to H2O2 (50 and 500 μM) 
for 3 h in serum free medium with and without l-pipecolate. 
Fig. 1. Reactions catalyzed by pipecolate oxidase and proline dehydrogenase. (A) Pipecolate oxidase (PIPOX) catalyzes the oxidation of l-pipeco-
late (Pipe) to Δ1-piperideine-6- carboxylate (P6C). P6C spontaneously hydrolyzes to form a-aminoadipic semialdehyde (AAS). (B) In an analogous re-
action, proline dehydrogenase (PRODH) catalyzes the oxidation of l-proline (Pro) to Δ1-pyrroline-5-carboxylate (P5C), which spontaneously hydro-
lyzes to glutamate γ-semialdehyde (GSA).  
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The protective effect of pipecolate was initially tested with dif-
ferent pipecolate concentrations (0.05–10 mM) and then 1, 
5, and 10 mM l-pipecolate were used in subsequent experi-
ments. After stress treatment, cell viability was quantified us-
ing the tetrazolium compound [3-(4, 5-dimethylthiazol-2-yl)-
5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium] 
(MTS) according to the recommendation of the manufacturers 
(Promega). The CellTiter-Glo Luminescent assay (Promega) was 
also used as an alternative method according to the recom-
mendation of the manufacturers. Percent cell survival was de-
termined relative to the appropriate controls. Stress tests with 
proline were performed similarly to pipecolate but using 5 mM 
l-proline. Stress tests were also performed in the presence of dif-
ferent inhibitor compounds. To inhibit the pentose phosphate 
pathway, HEK293 cells were incubated with 6-aminonicotinamide 
(6-AN) (50 μM) or dehydroepiandrosterone (DHEA) (50 μM) for 
24 h before adding pipecolate (10 mM) to the cell culture. Af-
ter 12 h incubation with pipecolate, cells were then treated with 
H2O2 as described above. Inhibition of the mechanistic target of 
rapamycin (mTOR) pathway was achieved by incubating HEK293 
cells with rapamycin (Calbiochem) at 10 and 100nM concentra-
tions for 2 h prior to H2O2 stress. Inhibition of both mTORC1 
and mTORC2 was achieved by incubating HEK293 cells with 10 
nM of KU-0063794 for 2 h prior to H2O2 stress. To inhibit Akt ac-
tivity, HEK293 were treated with 10 μM Akt Inhibitor VIII (Akti–
Calbiochem), which selectively inhibits Akt1/Akt2 activity, for 30 
min prior to H2O2 stress. Stock solutions of the inhibitor com-
pounds DHEA, 6-AN, rapamycin, and Akti were prepared in di-
methyl sulfoxide (DMSO). 
G6pdh Assay and NADPH Measurements 
Glucose-6-phosphate dehydrogenase (G6PDH) activity was mea-
sured according to the recommendation of the manufacturer 
(BioVision). One unit of enzyme is defined as 1 μmol of product 
formed per min at 37°C. Total protein concentration in the cell 
lysates was determined using the bicinchoninic acid (BCA) pro-
tein assay (Pierce) using bovine serum albumin as a standard. 
Cellular NADPH/NADP+ (MilliporeSigma) levels were estimated 
as previously described according to the manufacturer’s recom-
mendation [Natarajan et al., 2012]. 
Western Blot Analysis 
Cells grown in 10-cm diameter dishes were rinsed once with ice 
cold PBS and cell lysates were prepared using M-PER according 
to the recommendation of the manufacturers along with the 
addition of mammalian protease inhibitor cocktail (Sigma) and 
HALT-phosphatase inhibitor (Pierce). Lysates containing 50–100 
μg of protein were resolved by SDS–PAGE. Proteins were trans-
ferred to a PVDF membrane and visualized by immunoblotting. 
Mitochondrial Isolation 
Cells were released with trypsin and washed twice via centrifuga-
tion with ice cold PBS. Cell pellets were then resuspended in Tris 
buffer (5 mM, pH 7.4) containing 0.25 M sucrose, 1 mM EDTA, 
and mammalian protease inhibitor cocktail (Sigma). The resus-
pended cells were next hand homogenized using a dounce ho-
mogenizer for 1 min on ice. Mitochondria and cytosolic fractions 
were isolated by differential centrifugation as described [Natara-
jan et al., 2006a]. Briefly, cell homogenates were first centrifuged 
at 600g for 10 min to remove cell debris. Mitochondria were then 
pelleted at 17,000g for 15 min (4°C) and washed twice with mito-
chondrial suspension buffer (5 mM Tris, pH 7.4, 0.25 M sucrose). 
The post-mitochondrial supernatant was then centrifuged at 
32,000g for 20 min to isolate the peroxisome fraction [Natarajan 
et al., 2006a]. The peroxisomal fraction was resuspended in the 
mitochondrial suspension buffer and then centrifuged at 17,000g 
for 15 min to remove mitochondria. The supernatant was then 
centrifuged again at 32,000g for 20 min to collect pure peroxi-
somes [Natarajan et al., 2006a,b]. The postperoxisomal superna-
tant was centrifuged at 105,000g for 1 h to isolate the cytosolic 
fraction [Natarajan et al., 2006a]. Density-purified mitochondria 
were isolated on a discontinuous Histodenz [5-(N-2,3-Dihydroxy 
propylacetamido)-2,4,6-triiodo-N,N′-bis(2,3-dihydroxypropyl)
isophthalamide] gradient as described [Boldogh and Pon, 2007; 
Atkinson et al., 2011]. Briefly, the mitochondria-enriched fraction 
obtained from differential centrifugation was layered onto a dis-
continuous Histodenz gradient consisting of 14% and 22% lay-
ers dissolved in sorbitol buffer. Histodenz gradients were centri-
fuged at 303,000g for 1 h [Atkinson et al., 2011]. Mitochondrial 
fractions were then resuspended in mitochondrial suspension 
buffer and used for Western blot analysis. Total protein concen-
trations were quantified using the Bradford method (Bio-Rad). 
siRNA Transfection 
Cells were transfected with On-Target Plus Smart Pool siRNA 
of PIPOX and On-Target Plus Non-targeting Pool, referred to 
as control siRNA (Dharmacon RNA Technologies). siRNA trans-
fection was performed for 48 h before doing the stress test or 
whole cell extract collection. Knockdown was confirmed by im-
munoblotting. Following transfection, stress tests were per-
formed as described above. 
Statistical Analysis 
Data are expressed as mean ± standard deviation (SD). Statisti-
cal analysis was performed using student’s t-test. A P-value of < 
0.05 was considered to be statistically significant. 
Results 
Pipecolate Protects HEK293 Cells 
Pipecolate was previously shown to protect HEK293 cells against 
H2O2-induced cell death [Krishnan et al., 2008]. Here we pre-
treated HEK293 cells with different concentrations of pipecolate 
(0.05–10 mM) for 12 h prior to H2O2 stress treatment (0.5 mM, 
3 h). Pipecolate protected HEK293 cells against oxidative stress 
with significant protection observed at ≥0.75 mM pipecolate rel-
ative to control cells without pipecolate supplementation (Fig. 
2A and B) [Krishnan et al., 2008]. The protective effect of pipe-
colate was also investigated using luminescence quantification 
of ATP generation. In these assays, pipecolate increased cell sur-
vival in HEK293 cells (Fig. 2C) from 40% to 74%. 
Pipecolate protection was also examined at a more patho-
physiology-relevant level of oxidative stress by using a lower 
concentration of H2O2. At 50 μM H2O2 (3 h), percent cell survival 
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was significantly higher in HEK293 cells treated with pipecolate 
relative to control cells without pipecolate (Fig. 2D). Thus, pipe-
colate was able to protect cells against a H2O2 concentration that 
more closely mimics pathophysiological stress. 
PIPIX Knockdown by siRNA 
We next examined the effect of reducing endogenous PIPOX 
expression by transfecting HEK293 cells with PIPOX siRNA (siPI-
POX). Knockdown of PIPOX expression was confirmed by West-
ern blot analysis of whole cell lysates. PIPOX expression was 
observed to be significantly lower in HEK293 cells after 48 h of 
siPIPOX treatment relative to cells treated with control siRNA 
(Fig. 3A). In siPIPOX-transfected cells, pipecolate protection 
against H2O2-induced cell death was eliminated whereas in 
control siRNA treated cells pipecolate protection was still ob-
served (Fig. 3B). Pipecolate (1–5 mM) was also unprotective in 
siPIPOX-transfected cells exposed to pathophysiological levels 
of H2O2 (50 μM) (Fig. 3C). Next, we tested whether proline sup-
plementation could protect against H2O2 stress in cells treated 
with PIPOX siRNA. Proline significantly increased survival of 
HEK293 cells treated with PIPOX siRNA (Fig. 3D). These results 
show that although PIPOX can utilize proline as an alternative 
substrate, PIPOX is not essential for proline protection. Thus, it 
appears PIPOX is necessary for pipecolate protection. 
PIPOX Subcellular Localization 
Because PIPOX was observed to be essential for pipecolate pro-
tection, we sought to establish the subcellular localization of 
PIPOX in HEK293 cells. Human PIPOX terminates at the C-ter-
minus with an Ala-His-Leu tripeptide peroxisome targeting sig-
nal [IJlst et al., 2000], however, PIPOX has been shown previously 
to localize to the peroxisomes and the mitochondria depend-
ing on the species [IJlst et al., 2000]. Western analysis of PIPOX 
expression in the different subcellular compartments was per-
formed using highly purified mitochondria, peroxisomes, and cy-
tosolic fractions from HEK293 cells. Figure 4 shows that PIPOX 
was detected predominantly in isolated mitochondria. To check 
whether the purified mitochondria were contaminated with per-
oxisomes, we tested for the presence of catalase. High expres-
sion levels of catalase were observed in the peroxisomal fraction 
whereas catalase was not detected in the mitochondria indicat-
ing that the purified mitochondria were not contaminated with 
peroxisomes (Fig. 4). 
NADPH/NADP+ and Pentose Phosphate Pathway 
The effect of pipecolate on the NADPH/NADP+ ratio was mea-
sured in cells before and after H2O2 stress. The cellular NADPH/
NADP+ ratio in HEK293 cells decreased in control cells after 3 h 
of 500 μM H2O2 stress (Fig. 5A). In cells treated with pipecolate, 
Fig. 2. Oxidative stress protection of HEK293 cells by pipecolate. (A) HEK293 cells were treated without pipecolate (Con) and with different concen-
trations of pipecolate (Pipe) for 12 h (0.05–1 mM). Control and pipecolate treated cells were then incubated in serum free medium with and with-
out 0.5 mM H2O2 for 3 h. Percent cell survival was estimated using the MTS cell viability assay. (B) HEK 293 cells were treated with or without pipe-
colate (0.75–10 mM) for 12 h. Control and pipecolate treated cells were then incubated in serum free medium with and without 500 μM H2O2 for 3 
h. Percent cell survival was estimated using the MTS cell viability assay. (C) HEK293 cells treated with and without pipecolate (10 mM) for 12 h. Con-
trol and pipecolate treated cells were then incubated in serum free medium with and without 500 μM H2O2 for 3 h. Percent cell survival was deter-
mined using the Cell Titer-Glo Luminescent assay. (D) HEK293 cells were treated as above. Control and pipecolate (10 mM) treated cells were then 
incubated in serum free medium with and without 50 μM H2O2 for 3 h. Percent cell survival was determined using the Cell Titer-Glo Luminescent as-
say. Each value represents mean ± SD from five different experiments (n = 5) (* P <0.05).  
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however, the NADPH/NADP+ ratio increased during H2O2 stress 
resulting in a approximately fivefold higher ratio than in control 
cells (Fig. 5A). Next, we tested whether increased NADPH/NADP+ 
ratio with pipecolate treatment is via activation of the pentose 
phosphate pathway. Cells were treated with 6-aminonicotin-
amide (6-AN) and dehydroepiandrosterone (DHEA), which in-
hibit glucose 6-phosphate dehydrogenase (G6PDH) of the pen-
tose phosphate pathway. Treatment of cells with 6AN and DHEA 
showed a significant decrease in G6PDH activity (Fig. 5B) while 
the pipecolate-induced increase in the NADPH/NADP+ ratio was 
abolished in cells treated with the inhibitors (Fig. 5A). Further, we 
also tested the effect of pipecolate protection during inhibition 
of pentose phosphate pathway. Interestingly, pipecolate pro-
tection of HEK293 cells was still observed in the presence of the 
6-AN and DHEA indicating that the pentose phosphate pathway 
is not critical in these H2O2 stress experiments (Fig. 5C and D). 
Inhibition of mTORC 
The mechanistic target of rapamycin complex 1 (mTORC1) is 
known to be activated by amino acids [Lynch, 2001; Zoncu et al., 
2011] and we recently discovered a role for mTORC in proline 
protection [Natarajan et al., 2012]. To test whether mTORC1 and 
mTORC2 are also involved in pipecolate protection, HEK293 cells 
were incubated with 10nM rapamycin, a concentration previ-
ously shown to inhibit mTORC1 in cells [Lasithiotakis et al., 2008]. 
Treatment of cells with rapamycin did not attenuate pipecolate 
protection against H2O2 stress in HEK293 cells (Fig. 6A) suggest-
ing that mTORC1 is not involved. Treating cells with a higher con-
centration of rapamycin (100 nM), which inhibits mTORC1 and 
the Rictor-complex of mTOR (mTORC2) [Sarbassov et al., 2006], 
abrogated pipecolate protection (Fig. 6A) implying that mTORC2 
may be involved. This was further tested by treating HEK293 
cells with 10nM of KU-0063794, which also inhibits mTORC1 
and mTORC2. Similar to using a high concentration of rapamy-
cin, treatment of cells with KU-0063794 abolished pipecolate 
protection against H2O2 stress, suggesting a role for mTORC2 
in pipecolate protection (Fig. 6B). 
Role of Akt and FoxO3 during H2O2 Stress 
Akt/PKB (Protein kinase B) can significantly impact cell survival 
and proliferation and, is a downstream target of mTORC2 [Berndt 
et al., 2010; Altomare and Khaled, 2012]. Cells were treated with 
the Akt inhibitor, Akti, to test the involvement of Akt in pipeco-
late protection [Calleja et al., 2009]. At different concentrations 
of pipecolate (1 and 10 mM), Akti was observed to block pipe-
colate protection of HEK293 cells against H2O2 stress (Fig. 7A). 
Akti inhibition of Akt was confirmed by loss of phosphorylation 
at Akt residues T308 and S473 as shown in Figure 7B. Exposure of 
control cells to H2O2 increases phospho-Akt slightly at T308 and 
more significantly at S473 (Fig. 7B, –Akti). In the absence of H2O2, 
pipecolate does not increase the levels of phospho-Akt at T308 
and S473 relative to control cells (Fig. 7B, –Akti). However, in the 
presence of H2O2, pipecolate appears to significantly increase 
Fig. 3. Knockdown of PIPOX abolishes pipecolate protection. (A) West-
ern blot analysis of PIPOX in HEK293 cells transfected with control siRNA 
(siCon, 100 nM) and PIPOX siRNA (siPIPOX, 100 nM) for 48 h. Actin was 
used as a control. (B) Percent cell survival of control siRNA (siCon) or 
PIPOX siRNA (siPIPOX) treated HEK293 cells with and without 0.5mM 
H2O2 (3 h) in the absence (Con) and presence of 10mM pipecolate (Pipe). 
(C) Percent cell survival of control siRNA or PIPOX siRNA treated HEK293 
cells with and without 50 μM H2O2 (3 h) in the absence (Con) and pres-
ence of 1 or 5 mM pipecolate (Pipe). (D) Percent cell survival of control 
siRNA (siCon) or PIPOX siRNA (siPIPOX) treated HEK293 cells with and 
without 500μMH2O2 (3 h) in the absence (Con) and presence of 5mM 
proline. Percent cell survival in all experiments was estimated using the 
MTS cell viability assay. Each value represents mean ± SD of separate ex-
periments (n = 5) (* P <0.05).  
Fig. 4. Subcellular localization of PIPOX. Immunoblot analysis of PIPOX in 
mitochondria, peroxisomes, and cytosolic fractions isolated from HEK293 
cells. Actin, VDAC and catalase visualized with respective antibodies were 
used as fraction-specific markers for cytosol (Cyto.), mitochondria (Mito.), 
and peroxisomes (Per.), respectively.  
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the levels of phospho-Akt at S473 (Fig. 7B–D, –Akti). Treatment 
of cells with Akti abolished phosphorylation of Akt under all con-
ditions consistent with inhibition of the Akt signaling pathway 
(Fig. 7B–D, +Akti). In these experiments, no changes in the levels 
of total-Akt and the actin control were observed (Fig. 7B). The 
effects of Akti on other stress signaling pathways such as c-Jun 
N-terminal Kinase (JNK) were also examined. Akti did not per-
turb the phosphorylation status of JNK (Fig. 7E). 
Activation of Akt can lead to phosphorylation of several tran-
scriptions factors including the forkhead transcription factor O3 
(FoxO3). To test the downstream effects of Akt in pipecolate 
protection, phosphorylation of FoxO3 (Thr32) was examined af-
ter 0.5 and 3 h of H2O2 stress in cells with or without pipeco-
late. In control cells, a slight increase in phospho-FoxO3 lev-
els was observed with 0.5 h of H2O2 treatment (Fig. 8A and B). 
A much more dramatic increase in phospho-FoxO3, however, 
was observed with H2O2 (0.5 h) in the presence of pipecolate 
(Fig. 8A and B). Addition of Akti (+Akti) eliminated phosphory-
lation of FoxO3 indicating involvement of the Akt pathway (Fig. 
8A and B). At 3 h of H2O2 treatment, phospho-FoxO3 levels re-
mained slightly higher in pipecolate cells relative to control cells 
(Fig. 8C). These results suggest increased phosphorylation of 
FoxO3 is part of the mechanism by which pipecolate protects 
cells against oxidative stress. 
Discussion 
Here we show that PIPOX is required for the observed effects of 
pipecolate, a finding which is analogous to the role of PRODH 
in proline protection [Natarajan et al., 2012]. The specificity of 
proline and pipecolate protection is governed by PRODH and 
PIPOX, respectively. Although PIPOX can use proline as a sub-
strate, knockdown of PIPOX does not affect proline protection 
consistent with PRODH being the key proline catabolic enzyme. 
Conversely, pipecolate is not expected to be a substrate for 
PRODH [Zhu et al., 2002]. The mutual protective effects of pro-
line and pipecolate, both of which are transported into mamma-
lian cells via the sodium dependent IMINO transporter and the 
system IMINO transporter 1 [Kowalczuk et al., 2005; Takanaga et 
al., 2005], are likely due to the analogous flavin-dependent cat-
alyzed reactions of PRODH and PIPOX in mitochondria. The ox-
idation of these related amino acids involves reduction of a fla-
vin cofactor and subsequent electron transfer from the reduced 
Fig. 5. Effect of pipecolate on intracellular NADPH/NADP+ ratio. (A) The 
ratio of NADPH/NADP+ was determined for control (Con) and pipeco-
late-treated (Pipe, 10 mM) HEK293 cells with and without 500 μM H2O2 
(3 h). The NADPH/ NADP+ ratio was also estimated in cells incubated in 
the presence of 6AN or DHEA. Each value represents mean ± SD of sep-
arate experiments (n = 5) (* P <0.05). (B) Glucose 6-phosphate dehydro-
genase activity in HEK293 cells under different treatments. Percent sur-
vival of HEK 293 cells first treated with 6-amino nicotinamide (6-AN) (C) 
and dehydroepiandrosterone (DHEA). (D) Percent cell survival was esti-
mated using the MTS cell viability assay. Each value represents mean ± 
SD of separate experiments (n = 5) (* P <0.05).  
Fig. 6. Inhibition of mTORC2 blocks pipecolate protection. (A) Percent 
cell survival of HEK293 cells incubated with rapamycin (10 and 100 nM) 
and treated with and without 0.5mM H2O2 (3 h) in the absence (Con) and 
presence of 10mM pipecolate (Pipe). (B) Percent cell survival of HEK293 
cells incubated with Ku-0063794 (10 nM) and treated with and without 
0.5mM H2O2 (3 h) in the absence (Con) and presence of 10mM pipeco-
late (Pipe). Cells treated with DMSO were used as controls. Percent cell 
survival was estimated using the MTS cell viability assay. Each value rep-
resents mean ± SD of separate experiments (n = 5) (* P <0.05).  
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flavin to an electron acceptor. PRODH is a mitochondrial en-
zyme that couples the oxidation of proline to reduction of the 
ubiquinone pool in the mitochondrial membrane (Fig. 1) [Wan-
duragala et al., 2010; Liu et al., 2012]. PRODH activity has been 
reported to generate reactive oxygen species (ROS) leading to 
either cell survival or cell death [Liu et al., 2012; Natarajan and 
Becker, 2012; Zarse et al., 2012; Zhang et al., 2015]. Here, we 
show that PIPOX is also predominantly localized in the mito-
chondria. Whether PIPOX transfers electrons directly to the mi-
tochondrial electron transport chain is not clear but PIPOX has 
been shown to generate H2O2 during catalytic turnover [Wan-
ders et al., 1989; Mihalik et al., 1991]. Energy metabolism in the 
mitochondria is a potent source of ROS, which has been shown 
to have a plethora of effects on cell proliferation, death, and 
Fig. 7. Role of Akt in pipecolate protection. (A) Percent cell survival of HEK293 cells incubated without Akti (–Akti) or with 10 μM Akti (+Akti) and 
treated with and without 500 μM H2O2 stress (3 h) in the absence (Con) and presence of 1 or 10 mM pipecolate (Pipe). Cells treated with DMSO were 
used as controls. Percent cell survival was estimated using the MTS cell viability assay. Each value represents mean ± SD of separate experiments (n 
= 5) (* P <0.05). (B) Western analysis of P-Akt (T308 and S473), T-Akt and Actin in HEK293 cells treated with and without pipecolate (1 mM) for 12 
h and then incubated with and without 0.5 mM H2O2 for 0.5 h in serum free medium. Western analysis of P-Akt and T-Akt were also determined in 
cells with similar treatment conditions but in the presence of 10 μM Akt inhibitor (+Akti). Quantified levels of (C) P-Akt (T308) and (D) PAkt (S473) 
relative to total Akt (P-Akt/Akt). (E) Western analysis of P-JNK, and T-JNK in HEK293 cells treated with and without pipecolate (1 mM) for 12 h and 
then incubated with and without 0.5 mM H2O2 for 0.5 h in serum free medium. Western analysis of P-JNK and T-JNK were also determined with sim-
ilar treatment conditions but in the presence of 10 μM Akt inhibitor (+Akti). Blots shown are representative results from three independent experi-
ments. Each value represents the mean ± SD of separate experiments (n = 3) (* P <0.05).  
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other growth processes [Natarajan and Becker, 2012; Figueira 
et al., 2013]. We found that pipecolate shifts the redox status of 
the NADPH/NADP+ and helps maintain cellular NADPH/NADP+ 
ratios during stress consistent with PIPOX having a role in redox 
homeostasis. However, the increased NADPH/NADP+ ratio and 
pentose phosphate pathway were found not be critical for pipe-
colate protection against H2O2 stress. Further studies are under-
way to elucidate the mechanism by which pipecolate influences 
the redox environment during oxidative stress. 
Finding that PIPOX was mainly localized in mitochondria of 
HEK293 cells was unexpected. Previous studies of PIPOX in rat 
and human liver detected PIPOX activity in both mitochondria 
and peroxisomes [Wanders et al., 1989; Rao et al., 1993]. The 
subcellular localization of PIPOX has been shown to be species-
dependent with localization in the peroxisomes suggested to 
predominate in humans [Mihalik and Rhead, 1989, 1991]. In hu-
man fibroblasts overexpression of PIPOX resulted in localization 
of PIPOX in the peroxisomes as detected by immunofluorescence 
staining [IJlst et al., 2000]. Currently known peroxisomal target-
ing signals (PTS) are the C-terminal PTS-1 and the N-terminal 
PTS-2 [Gould and Collins, 2002; Wolf et al., 2010]. PIPOX has a 
PTS-1 sequence of Ala-His-Leu and does not have a mitochon-
drial target sequence [IJlst et al., 2000]. Bioinformatics analysis 
of PIPOX using MitoProt [Claros and Vincens, 1996], a program 
that does not rely on identifying a targeting peptide but instead 
evaluates up to 47 parameters, gives a low probability (MitoProt 
score of 15%) for PIPOX import into mitochondria despite PIPOX 
not having a mitochondrial targeting sequence. Another bioin-
formatics tool, WoLF PSORT [Horton et al., 2007], predicts that 
PIPOX is favored to be localized in the mitochondria rather than 
in the peroxisomes. It is established that peroxisomal targeting 
sequences do not necessarily limit protein localization to the 
peroxisomes [Wolf et al., 2010]. In addition, it is becoming more 
recognized that proteins can be located in more than one com-
partment [O’Byrne et al., 2003; Hogenboom et al., 2004; Taylor 
et al., 2004; Yogev and Pines, 2011; Islinger et al., 2012]. Dual lo-
calization of proteins can occur by various mechanisms involv-
ing two target signals in a single polypeptide and target signals 
that are inaccessible or ambiguous [O’Byrne et al., 2003; Hogen-
boom et al., 2004; Taylor et al., 2004; Yogev and Pines, 2011; Is-
linger et al., 2012]. 
Mitochondrial localization of PIPOX in HEK293 cells is consis-
tent with its role in the lysine catabolic pathway, which involves 
mitochondrial enzymes such as AASDH (also known as AL-
DH7A1) [Brocker et al., 2010; Struys and Jakobs, 2010; Stockler et 
al., 2011; Luo and Tanner, 2015]. Recently, PIPOX was suggested 
Fig. 8. Involvement of FoxO3 in pipecolate protection. (A) Western analysis of P-FoxO3 (P-Thr32) and T-FoxO3 (total FoxO3) in HEK293 cells treated 
with and without pipecolate (1 mM) for 12 h and then incubated with and without 0.5 mM H2O2 for 0.5 h in serum free medium. Blots are shown for 
experiments performed in the absence (–Akti) and presence (+Akti) of 10 μM Akt inhibitor (B) Quantified levels of P-FoxO3 (T32) relative to T-FoxO3 
from Western blots as described in panel A in the absence (–Akti) and presence (+Akti) of Akt inhibitor. (C) Same as in panel A but incubated with 
and without 0.5 mM H2O2 for 3 h in serum-free medium. Blots shown are representative results from three independent experiments. Each value rep-
resents the mean ± SD of separate experiments (n = 3) (* P <0.05).      
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to function as a metabolic repair enzyme by minimizing pipeco-
late accumulation and increasing the overall conversion of lysine 
to glutaryl-CoA [Struys and Jakobs, 2010; Van Schaftingen et al., 
2013]. Pyrroline-5-carboxylate reductase (P5CR) has been pro-
posed to catalyze the NADPH-dependent reduction of P6C to 
pipecolate as a side reaction thereby diminishing lysine catabolic 
efficiency [Struys and Jakobs, 2010; Van Schaftingen et al., 2013]. 
The preferred substrate for P5CR is Δ1-pyrroline-5-carboxylate, 
but P5CR from Escherichia coli has been shown to convert P6C 
to pipecolate [Fujii et al., 2002]. Humans have three isoforms of 
P5CR known as PYCR1, PYCR2, and PYCRL [Reversade et al., 2009; 
De Ingeniis et al., 2012]. PYCR1 and PYCR2 were recently shown 
to localize in the mitochondria [Reversade et al., 2009; De Inge-
niis et al., 2012]. Finding that PIPOX is also localized in the mi-
tochondria further supports a repair role for PIPOX, which mer-
its future investigation. 
The results here with pipecolate and previously with proline 
[Natarajan et al., 2012], indicate that the protective effects of 
these amino acids involve the Akt and its downstream media-
tors. In the previous study with proline, PRODH was shown to 
increase Akt phosphorylation (Ser473) and phosphorylation of 
the Akt downstream target, FoxO3 [Natarajan et al., 2012]. Phos-
phorylation of FoxO3 by Akt prevents activation of pro-apop-
totic genes thus promoting cell survival [Guo et al., 2011]. In this 
study, inhibition of Akt abolished phosphorylation of FoxO3 and 
the protective effect of pipecolate. Thus, the protective mecha-
nism of pipecolate appears to be mediated by Akt and FoxO3. 
As previously observed with proline, dual inhibition of mTORC 
complexes, blocks pipecolate protection against oxidative stress. 
These observations indicate that mTORC2 may be involved in the 
mechanism of cell protection. mTORC2 has been shown to ac-
tivate Akt via phosphorylation of Ser473 [Guo et al., 2011; Mu-
rata et al., 2011]. How pipecolate and proline influence mTORC2 
and Akt signaling is not clear but amino acids have been shown 
to induce mTORC1 and mTORC2 in mammalian cells [Tato et al., 
2011]. In addition, evidence has been reported for mTORC2 be-
ing activated by mitochondrial ROS suggesting that the intracel-
lular redox environment modulates mTORC2 [Kumari Kanchan et 
al., 2012]. Whether ROS is a key mediator by which proline and 
pipecolate metabolism meditate mTORC2 and Akt pathway ac-
tivity remains to be determined. 
In summary, we show that pipecolate metabolism leads to 
protection against H2O2 stress in mammalian cells. Our findings 
expand the potential role of pipecolate metabolism in mediat-
ing cell signaling. Previous studies reporting that pipecolate im-
pacts oxidative stress were focused on exploring the role of pipe-
colate in neurological function. Incubation of rat cerebral cortex 
supernatants with pipecolate for 1 h was shown to decrease the 
activity of antioxidant enzymes, an effect that could be blocked 
by lipoic acid [Dalazen et al., 2014]. Pipecolate was also shown 
to stimulate apoptotic cell death in neurons [Matsumoto et al., 
2003]. Treatment of mouse neuroblastoma cells with d- or l-
pipecolate over 72 h decreased cell viability with a racemic mix-
ture of dl-pipecolate having the most toxic effect [Matsumoto 
et al., 2003]. Because d-pipecolate decreased cell viability, the 
mechanism appears to be independent of pipecolate oxidase ac-
tivity, which is specific for l-pipecolate [Matsumoto et al., 2003]. 
Different roles for d- and l-pipecolate have also been found in 
other biological contexts such as l-pipecolate acting as an anti-
hypertensive by competitively inhibiting the angiotensin I-con-
verting enzyme, whereas, the d-enantiomer does not have an 
antihypertensive function [Vranova et al., 2013]. Future studies 
will investigate the protective role of pipecolate metabolism and 
downstream pathways involving mTORC2, Akt and FoxO3 using 
other cell types to broaden our understanding of how pipeco-
late impacts the cellular redox environment.  
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